Pakistan Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

Pakistan’s infection control market is evaluated at US$22.322 million for the year 2020 and is projected to grow at a CAGR of 5.07% to reach a market size of US$31.553 million by the year 2027. In Pakistan, the top ten causes of death are ischemic heart disease (8%), cancer (8%), lower respiratory infections (8%), stroke (6%), diarrheal diseases (6%), neonatal encephalopathy (5%), chronic obstructive pulmonary disease (5%), TB (5%), pre-term birth complications (4%), and Diabetes (3%). Pakistan is one of three remaining countries where indigenous wild poliovirus (WPV) transmission has never been interrupted. The number of confirmed WPV cases increased to 198 in 2011. Also, in 2011, Pakistan began implementing a national action plan in response to the World Health Organisation (WHO) declaring a global polio emergency. Further, the health care provision in Pakistan is the responsibility of the government. The healthcare system has expanded gradually with an extensive network of health facilities, workforce, and services across the country. Currently, the public health care system comprises 1,167 hospitals, 5,695 dispensaries, 5,464 basic health units, 675 rural health centres, 733 mother and child health centres, and allied medical professionals, i.e., doctors, nurses, midwives, and pharmacists. As of FY2016, there are 18,4711 doctors, 16,652 dentists, and the availability of 118,869 hospital beds in the country.

Cumulative health expenditures of the federal and the provinces are estimated at Rs 384.57 billion for the fiscal year 2017-18, which is 31.75 % higher than the actual expenditures of Rs 291.90 billion realized during the fiscal year 2016 – 17. A brief look into the previous year’s performance reveals that total health expenditures increased both in terms of growth and a percentage of GDP. It grew by 29.54 % to stand at Rs 291.90 billion during the fiscal year 2016 – 17 against Rs 225.87 billion in 2015 – 16. Health expenditures surpassed the budget allocation of Rs 273.34 billion for 2016-17. While in terms of GDP, health expenditure increased to 0.91 percent during the fiscal year 2016-17 from 0.77 recorded in 2015-16. From July-February, 2017-18, health expenditures consumed 43.5 percent of budget allocation to reach Rs 167.16 billion against the expenditure of Rs 121.57 billion in the comparable period of the fiscal year 2016-17. In terms of growth, it increased by 37.51 percent. Viewed from GDP, it increased to 0.49 percent during July - February 2017-18 from 0.38 percent recorded in the same period of the fiscal year 2016-17.

Further, a total of Rs 15 billion was allocated to Prime Minister Health Programme (PSDP) 2017-18 for the two phases of the program. Further, due to increased healthcare investments in 2017, the number of public sector hospitals has increased to 1,211, of which 5,508 are basic health units (BHUs), 676 rural health centres (RHCs), and 5,697 dispensaries. These facilities, together with 208,007 doctors, 20,463 dentists, and 103,777 nurses, bring the current ratio of one doctor for 957 persons, 9,730 people per dentist, and the availability of one hospital bed for 1,580 people and shows that the number under each establishment is increasing.  Therefore, with the prevalence of diseases, the involvement of the government and its subsequent expenditure on healthcare towards setting up of initiatives, among others, to uphold the wellbeing of the patients as well as high patient turnover as exemplified by the incremental growth of total number beds till 2015 across various healthcare points, the need for adhering to strict infection prevention protocol by the healthcare segment of the nation is of paramount importance in order to prevent any further complications like hospital-acquired infection (HAI). This need will drive the demand for infection prevention products during the forecast, thereby throttling the growth of the Infection Control Market of Pakistan during the forecast period.

COVID-19 SCENARIO

The coronavirus infection spread quickly and was aided in part by the market for controlling acquired diseases because there were few protective measures in place. The majority of the cases of COVID-19 among medical personnel were brought on by contact and infection transmission within hospital settings. Hospital-acquired infections received a lot more attention after the pandemic's seriousness was apparent, and numerous controls were put in place to reduce them. As a result, hospital-acquired infection control equipment was in extremely high demand. As the pandemic ends, it is anticipated that demand for hospital-acquired infection control devices would decline. However, rising awareness of hospital-acquired infections is anticipated to keep the industry afloat at a modest rate during the ensuing years.

Key Developments

• March 2020- The preferred product for COVID-19 infection prevention in Pakistan is ZIX VIROX®. The renowned disinfectant Zix Virox® is being used by Pakistan's distributor of ZIX goods, FORWARD SOLUTIONS, to disinfect public spaces, including the airport, in accordance with government instructions. Additionally, nationwide efforts to clean and disinfect have been stepped up. To ensure effective disinfection of common areas, Forward Solutions employs Zix Virox disinfectant when cleaning and sanitising public buildings.
• July 2020- At its Landhi location in Pakistan, the colour and speciality chemicals manufacturer Archroma announced that bulk production of a new line of hand sanitizers known as Kieralon HS had begun. Production of the hand sanitizer, which was created by the R&D team at the Archroma Center of Excellence in Karachi, started in May in compliance with guidelines from the World Health Organization.

Pakistan Infection Control Market Scope:

Market Segmentation

• By Product
  • Disinfectants
  • Sterilization
    • Low-Temperature Sterilization
    • Heat Sterilization
    • Contract Sterilization
• By End-User Industry
  • Healthcare
  • Food and Beverage
  • Chemical

3M   

Belimed AG      

Miele    

Reckitt Benckiser (Pakistan) Ltd 

Tuttnauer